Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Sirolimus-related anal ulceration in a female patient after allogeneic stem cell transplantation

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Saunders RN, Metcalfe MS, Nicholson ML . Rapamycin in transplantation: a review of the evidence. Kidney Int 2001; 59: 3–16.

    Article  CAS  Google Scholar 

  2. Augustine JJ, Bodziak KA, Hricik DE . Use of sirolimus in solid organ transplantation. Drugs 2007; 67: 369–391.

    Article  CAS  Google Scholar 

  3. Cutler C, Antin JH . Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 34: 471–476.

    Article  CAS  Google Scholar 

  4. Mahé E, Morelon E, Lechaton S, Sang KH, Mansouri R, Ducasse MF et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation 2005; 79: 476–482.

    Article  Google Scholar 

  5. Özcan D, Seçkin D, Ada S, Haberal M . Mucocutaneous disorders in renal transplant recipients receiving sirolimus-based immunosuppressive therapy: a prospective, case-control study. Clin Transplant 2013; 27: 742–748.

    PubMed  Google Scholar 

  6. Fricain JC, Cellerié K, Sibaud V, Catros S, Taïeb A, Merville P . Oral ulcers in kidney allograft recipients treated with sirolimus. Ann Dermatol Venereol 2008; 135: 737–741.

    Article  Google Scholar 

  7. Neff GW, Montalbano M, Slapak-Green G, Meyer D, Berney T, Safdar K et al. Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. Transplant Proc 2003; 35: 3029–3031.

    Article  CAS  Google Scholar 

  8. Montalbano M, Neff GW, Yamashiki N, Meyer D, Bettiol M, Slapak-Green G et al. A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation 2004; 78: 264–268.

    Article  CAS  Google Scholar 

  9. Schaffellner S, Jakoby E, Kniepeiss D, Stadlbauer V, Duller D, Iberer F et al. Center experience in liver transplantation (LTX): management of dermal side effects caused by sirolimus. Int Immunopharmacol 2005; 5: 137–140.

    Article  CAS  Google Scholar 

  10. Johnston LJ, Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ et al. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 47–55.

    Article  CAS  Google Scholar 

  11. Busca A, Locatelli F, Moscato D, Falda M . Sirolimus-related toxicity in stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 647–649.

    Article  Google Scholar 

  12. Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K et al. Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation 2001; 72: 1924–1929.

    Article  CAS  Google Scholar 

  13. Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D et al. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood 2014; 124: 1372–1377.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Vigouroux.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haïk, L., Beylot-Barry, M., Vigouroux, S. et al. Sirolimus-related anal ulceration in a female patient after allogeneic stem cell transplantation. Bone Marrow Transplant 51, 132–133 (2016). https://doi.org/10.1038/bmt.2015.198

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.198

This article is cited by

Search

Quick links